Literature DB >> 15063158

Effects of nociceptin on the exploratory behavior of mice in the hole-board test.

Junzo Kamei1, Yasuhiro Matsunawa, Shigeo Miyata, Shun-ichi Tanaka, Akiyoshi Saitoh.   

Abstract

The effects of nociceptin on the exploratory behavior of mice were examined using an automatic hole-board apparatus. A low dose of nociceptin (0.01 nmol, i.c.v.) had an anxiolytic effect, as reflected by an increase in head-dipping behavior. However, high doses of nociceptin (1-5 nmol, i.c.v.) produced a dose-dependent anxiogenic effect, as reflected by a decrease in head-dipping behavior. Both the anxiolytic and anxiogenic effects of nociceptin were antagonized by nocistatin, an opioid receptor-like 1 (ORL1) receptor antagonist. Although a low dose (0.01 nmol, i.c.v.) of nociceptin significantly increased the rate of serotonin (5-hyroxytryptamine, 5-HT) turnover in the hippocampus, a high dose (5 nmol, i.c.v.) of nociceptin significantly decreased this turnover in the amygdala. Furthermore, the anxiolytic effect of nociceptin at a low dose was antagonized by N-[2-[4-(2-methoxyphenyl)-1-piperazinyl] ethyl]-N-(2-pyridinyl) cyclo-hexanecarboxamide 3HCl (WAY100635), a 5-HT1A receptor antagonist. On the other hand, the anxiogenic effect of nociceptin at a high dose was antagonized by R(+)-2-dipropylamino-8-hydroxy-1,2,3,4-tetrahydronaphthalene hydrobromide (8-OH-DPAT), a 5-HT1A receptor agonist. In conclusion, the results of this study suggest that nociceptin has dose-related anxiolytic and anxiogenic effects as a result of the activation of ORL1 receptors. The present results also suggest that a low dose of nociceptin has an anxiolytic effect via the activation of 5-HT ergic function in the hippocampus, while a high dose of nociceptin has an anxiogenic effect via the inhibition of 5-HT ergic function in the amygdala.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063158     DOI: 10.1016/j.ejphar.2003.12.020

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

1.  ROCK inhibition produces anxiety-related behaviors in mice.

Authors:  Akiyoshi Saitoh; Mitsuhiko Yamada; Misa Yamada; Shinya Kobayashi; Noritaka Hirose; Kazuo Honda; Junzo Kamei
Journal:  Psychopharmacology (Berl)       Date:  2006-07-13       Impact factor: 4.530

2.  Identification of NIPSNAP1 as a nocistatin-interacting protein involving pain transmission.

Authors:  Emiko Okuda-Ashitaka; Toshiaki Minami; Shingo Tsubouchi; Hiroshi Kiyonari; Akihiro Iwamatsu; Tetsuo Noda; Hiroshi Handa; Seiji Ito
Journal:  J Biol Chem       Date:  2012-02-06       Impact factor: 5.157

3.  Activation of nociceptin/orphanin FQ peptide receptors disrupts visual but not auditory sensorimotor gating in BALB/cByJ mice: comparison to dopamine receptor agonists.

Authors:  Aurelia Ces; David Reiss; Ondine Walter; Jürgen Wichmann; Eric P Prinssen; Brigitte L Kieffer; Abdel-Mouttalib Ouagazzal
Journal:  Neuropsychopharmacology       Date:  2011-08-31       Impact factor: 7.853

4.  Modification of anxiety-like behaviors by nociceptin/orphanin FQ (N/OFQ) and time-dependent changes in N/OFQ-NOP gene expression following ethanol withdrawal.

Authors:  Harinder Aujla; Rosalia Cannarsa; Patrizia Romualdi; Roberto Ciccocioppo; Rémi Martin-Fardon; Friedbert Weiss
Journal:  Addict Biol       Date:  2012-07-15       Impact factor: 4.280

5.  Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task.

Authors:  Laila Asth; Nataly Correia; Bruno Lobão-Soares; Thereza C Monteiro De Lima; Remo Guerrini; Girolamo Calo'; Vanessa P Soares-Rachetti; Elaine C Gavioli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-10-16       Impact factor: 3.000

6.  Nocistatin and nociceptin modulate c-Fos expression in the mice thalamus.

Authors:  Jamil Ahsan Kazi
Journal:  Neurol Sci       Date:  2012-01-13       Impact factor: 3.307

7.  Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair.

Authors:  Celia Goeldner; Will Spooren; Jürgen Wichmann; Eric P Prinssen
Journal:  Psychopharmacology (Berl)       Date:  2012-01-18       Impact factor: 4.530

8.  Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands.

Authors:  L Asth; C Ruzza; D Malfacini; I Medeiros; R Guerrini; N T Zaveri; E C Gavioli; G Calo'
Journal:  Neuropharmacology       Date:  2016-02-08       Impact factor: 5.250

9.  Mice lacking synapsin III show abnormalities in explicit memory and conditioned fear.

Authors:  B Porton; R M Rodriguiz; L E Phillips; J W Gilbert; J Feng; P Greengard; H-T Kao; W C Wetsel
Journal:  Genes Brain Behav       Date:  2009-11-24       Impact factor: 3.449

Review 10.  Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands.

Authors:  Elaine C Gavioli; Girolamo Calo'
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-21       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.